Why Vanda Pharmaceuticals Shares Are Trading Higher By Around 33%; Here Are 20 Stocks Moving Premarket - AIOS Tech (NASDAQ:AIOS), Blue Hat Interactive (NASDAQ:BHAT)

Core Viewpoint - Vanda Pharmaceuticals Inc. has received FDA approval for BYSANTI™ (milsaperidone), marking a significant advancement in the treatment of bipolar I disorder and schizophrenia, which could enhance the company's position in the psychiatric innovation sector [1] Company Summary - Vanda Pharmaceuticals Inc. shares experienced a sharp increase in pre-market trading following the announcement of FDA approval for BYSANTI™ [1]